Treatment
Mesenchymal Stem Cells clinical trials
We’re tracking 124 recruiting studies that include Mesenchymal Stem Cells, each written for real people, not researchers, below.
Recruiting studies
- NCT07313020Enrolling by invitationEarly Phase 1
Handheld imaging to track stem cells in knee osteoarthritis
This trial tests a new handheld imaging device (MPI) to track stem cells injected into the knee. It aims to see if the device can safely monitor how the stem cells move and work in people with knee osteoarthritis.
Haikou, HainanAges 18–75 - NCT05854615RecruitingPhase 4
Stem cell treatment for painful poor blood flow in limbs
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
Kuala LumpurAges 18–65 - NCT07400328RecruitingPhase 2
Stem cell injection to prevent severe mouth sores in transplant
This trial is testing a single injection called Amimestrocel to prevent severe mouth sores in people getting a stem cell transplant. The study is for adults who are receiving high-dose conditioning with total body irradiation or melphalan, which often cause painful mouth inflammation.
Suzhu, JiangsuAges 18–65 - NCT06954740RecruitingPhase 2
Stem cell treatment for acute kidney injury
This study tests a special type of stem cell treatment called mesenchymal stromal cells (Amimestrocel) for patients with acute kidney injury. The goal is to see if this treatment can help kidneys recover better than standard care.
Beijing, Beijing MunicipalityAges 18–75
Common questions
- Are there clinical trials studying Mesenchymal Stem Cells?
- Yes. Clin2 currently lists 124 recruiting studies that include Mesenchymal Stem Cells, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Mesenchymal Stem Cells trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Mesenchymal Stem Cells an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Mesenchymal Stem Cells or a specific trial is right for you.
Related treatments
- Human Umbilical Cord Mesenchymal Stem Cells
- Umbilical Cord Mesenchymal Stem Cell
- Mesenchymal Stromal Cells
- Mesenchymal Stem Cell
- Umbilical Cord Blood-Derived Stem Cells and Exosomes
- Base-edited hematopoietic stem and progenitor cells
- Β-globin Restored Autologous Hematopoietic Stem Cells
- CAR-T cells
- CD19 CAR-T cells
- anti-CD19 CAR-T cells
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.